Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the safety and efficacy of two medications--clonidine and methylphenidate--alone or in combination to treat attention deficit hyperactivity disorder in children ages 4 through 6.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cincinnati
• Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
• Treatments: Clonidine; Methylphenidate

Criteria

Inclusion Criteria:

• Child with ADHD

• Child ages 4 through 6

• Child attending a structured preschool or daycare

Exclusion Criteria:

• Presence of a tic disorder of any kind or a known active heart disease for which it would be unsafe to use the study drugs

• Presence of pervasive developmental disorder, autism, mental retardation, or serious psychiatric illness

• Child not attending a structured preschool or daycare